XSpray

Improving-formulation-of-Protein-Kinase-Inhibitors

At XSpray we specialize in the formulation of protein kinase inhibitors, many of which suffer from formulation related medical problems:

Reducing – pH dependent absorption

Minimizing – Food effect

Improving – Limited solubility

Reducing – Highly variable bioavailability

Expanding – Narrow therapeutic range

Minimizing – Drug-drug interactions

XSpray’s HyNap™ is a PLATFORM TECHNOLOGY that addresses the formulation related drawbacks of small molecule PKI’s and can improve the solubility and bioavailability of even the most challenging drug substances.

Whether you’re developing a new drug or looking to improve the product profile of a currently marketed drug we can help you get to market faster with a better product.

Overcoming the significant problems associated with formulating challenging compounds